Documentary highlights new targets to potentially treat motor neurone disease
Pharma Times
NOVEMBER 14, 2023
The terminal condition currently affects around 5,000 people in the UK - News - PharmaTimes
Pharma Times
NOVEMBER 14, 2023
The terminal condition currently affects around 5,000 people in the UK - News - PharmaTimes
Bio Pharma Dive
NOVEMBER 14, 2023
The Series A round for three-year-old startup VectorY is one of the largest private financings in Europe this year, Forbion said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 14, 2023
So much of our health is tied to banking good quality sleep every night, and a new four-week experiment has revealed a simple way anyone can improve the quality of their slumber: keeping the bedroom well-ventilated.
Bio Pharma Dive
NOVEMBER 14, 2023
The lobbying group urged broader health insurance coverage for treating obesity, including with GLP-1 agonists like Wegovy.
Pharmaceutical Technology
NOVEMBER 14, 2023
Concerns have been raised over the suitability of current FDA-approved treatments for myelofibrosis, due to the negative associations with anaemia.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 14, 2023
Indian healthcare looks at pharmacogenomics, the study of influence of genetic factors on drug response, in patient care as comprehensive genetic tests gain ground. Global healthcare sector has witnessed a paradigm shift with the emergence of pharmacogenomics (PGx) as a game changing trend.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Fierce Pharma
NOVEMBER 14, 2023
Earlier this month, Pfizer’s $3.5 billion cost-cutting campaign crossed overseas to Ireland. Now, just a week later, Pfizer is announcing hundreds more job cuts in the U.K. | Pfizer plans to cut approximately 500 roles and ax its Pharmaceutical Sciences Small Molecule capabilities at its site in Sandwich in Kent in the U.K. The move is a consequence of Pfizer’s enterprisewide cost realignment program, which the drugmaker unveiled in mid-October.
Pharmaceutical Technology
NOVEMBER 14, 2023
Novartis Pharma has signed an exclusive worldwide licence agreement for Legend Biotech Ireland’s DLL3-targeting CAR-T cell therapies.
Antidote
NOVEMBER 14, 2023
For Carla Greenbaum, M.D., growing up in the era of space travel and the moon landing kindled a lifelong interest in science. That interest influenced her career trajectory, and she’s now a leading investigator at Benaroya Research Institute where she has studied the natural history of type 1 diabetes (T1D) since 2000. Her work focuses on finding the cause of autoimmunity and developing targets for treatment, which she finds “incredibly exciting and inspiring—like landing on the moon!
Pharmaceutical Technology
NOVEMBER 14, 2023
VectorY Therapeutics secured $138m in a Series A funding round to progress its vectorised antibody programmes in neurodegenerative diseases.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Fierce Pharma
NOVEMBER 14, 2023
Johnson & Johnson and Bayer’s wide-spanning VOYAGER PAD study continues to be a gold mine for proving its Xarelto’s worth in several subsets of patients with peripheral artery disease (PAD).
Pharmaceutical Technology
NOVEMBER 14, 2023
Teva Pharmaceuticals and Royalty Pharma have partnered on a clinical research programme for olanzapine LAI (TEV-‘749), for schizophrenia.
Pharma Times
NOVEMBER 14, 2023
The projects will explore early-stage ideas at the frontiers of bioscience - News - PharmaTimes
Pharmaceutical Technology
NOVEMBER 14, 2023
Health Canada has approved Ipsen-Medison Pharma’s Bylvay to treat pruritus associated with progressive familial intrahepatic cholestasis.
XTalks
NOVEMBER 14, 2023
Last month, TIME Magazine unveiled its “ Best Inventions of 2023 ” list, which included 13 food inventions (up from nine last year). The magazine spotlighted 200 groundbreaking inventions that promise to transform our daily interactions, work methodologies and overall future outlook. To select the winners, TIME gathered nominations from its global network of editors and correspondents, complemented by an online application process for submissions.
Pharmaceutical Technology
NOVEMBER 14, 2023
South Korea has been busy with reforms that aim to expedite the introduction of new innovative drugs into its national insurance system.
XTalks
NOVEMBER 14, 2023
Novo Nordisk shared new clinical trial data that shows its obesity drug Wegovy (semaglutide) can also reduce the risk of various heart complications, including heart attack, in certain individuals. Novo presented the results of the study at the American Heart Association (AHA) Scientific Sessions this past weekend in Philadelphia, which were also published in the New England Journal of Medicine.
Pharmaceutical Technology
NOVEMBER 14, 2023
AstraZeneca has announced its strategy for the cardiometabolic market, in particular for treating obesity and its co-morbidities
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
NOVEMBER 14, 2023
The new company, Mural Oncology, will continue registrational studies of its IL-2 cytokine in melanoma and ovarian cancer utilizing a $275 million cash runway expected to take them to the end of 2025.
Pharmaceutical Technology
NOVEMBER 14, 2023
MBrace Therapeutics has secured $85m in a Series B funding round to advance clinical development of ADCs for oncology targets.
Cloudbyz
NOVEMBER 14, 2023
Clinical trials play a pivotal role in bringing new medical devices to market, ensuring their safety, efficacy, and compliance with regulatory standards. However, the landscape of medical device clinical trial operations is not without its challenges, and one of the most significant obstacles is dealing with legacy and disconnected systems. In this blog, we will delve into the complexities associated with legacy systems and disconnected data in the context of medical device clinical trials, expl
Pharmaceutical Technology
NOVEMBER 14, 2023
The company intends to use the funds to advance its cancer vaccine clinical pipeline, including a colorectal cancer vaccine.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Channels
NOVEMBER 14, 2023
It’s time for our most popular event of the year! Dr. Adam J. Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. to 1:30 p.m. ET. This post describes the event, outlines the pricing options, and explains how to purchase a registration.
Pharmaceutical Technology
NOVEMBER 14, 2023
With demand for drug products high, biopharma will need bold strategies to address sustainability challenges of the future.
Outsourcing Pharma
NOVEMBER 14, 2023
Owlstone Medical's exegenous volatile organic compound (EVOC) breath test can reveal signs of liver cirrhosis and portal hypertension, a study has found.
Pharmaceutical Technology
NOVEMBER 14, 2023
Telix with pay $2m upfront, with $33m on closing and up to $90m in milestone-based payments.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
NOVEMBER 14, 2023
Months after the FDA lifted its partial hold on their Phase II multiple myeloma program, Kite and Arcellx are expanding their existing development and commercialization collaboration in the blood cancer space.
Pharmaceutical Technology
NOVEMBER 14, 2023
Orphelia has lined its discovery pipeline with a number of pediatric CNS and rare cancer indications.
Fierce Pharma
NOVEMBER 14, 2023
One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. | One study in AstraZeneca’s elaborate R&D plan for lung cancer has reached a dead end. Failure of the Imfinzi-concurrent-chemoradiotherapy regimen deals a blow to AZ’s goal to target more than half of lung cancer patients by 2030.
Pharmaceutical Technology
NOVEMBER 14, 2023
When it comes to drug development, there's no substitute for speed.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Let's personalize your content